Evidence map›Paper›PMID 39823307›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2025

Assessing the Impact of Messages About Reduced Nicotine Cigar Products Among People Who Use Little Cigars and Cigarillos: Insights From a Discrete Choice Experiment.

Charity A Ntansah, Lucy Popova, James W Hardin, Minji Kim, Kymberle L Sterling, Reed M Reynolds, Emily E Hackworth, David L Ashley, Katherine C Henderson, Bo Yang and 1 more

Abstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Examining Spontaneous Cognitive and Emotional Reactions to Messages About Very Low Nicotine Cigarettes (VLNCs).Health education & behavior : the official publication of the Society for Public Health Education · 2026
    Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Charity A NtansahRutgers Institute for Nicotine and Tobacco Studies, New Brunswick, NJ, USA.ORCID 0009-0003-1488-6375
Lucy PopovaSchool of Public Health, Georgia State University, Atlanta, GA, USA.ORCID 0000-0002-3450-4579
James W HardinDepartment of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Minji KimDepartment of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.ORCID 0000-0002-7715-6826
Kymberle L SterlingRutgers Institute for Nicotine and Tobacco Studies, New Brunswick, NJ, USA.
Reed M ReynoldsCommunication Department, University of Massachusetts Boston, Boston, MA, USA.
Emily E HackworthMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-5078-5710
David L AshleyTRSConsulting56 LLC, Lilburn, GA, USA.ORCID 0000-0002-1060-5893
Katherine C HendersonSchool of Public Health, Georgia State University, Atlanta, GA, USA.ORCID 0000-0001-9905-8648
Bo YangDepartment of Communication, University of Arizona, Tucson, AZ, USA.
James F ThrasherDepartment of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.ORCID 0000-0001-6418-4863

Funding

Communicating about nicotine tobacco product standard in cigar productsR01CA239308 · NCI · GEORGIA STATE UNIVERSITY · PI Lyudmila Popova · 2019 to 2026
$3.8M
NCI NIH HHS R01 CA239308NCI NIH HHS R01CA239308-03S1
6 · The paper itself

Abstract

introductionThe US Food and Drug Administration's (FDA) pursuit of a low nicotine standard for cigarettes raises concerns that a focus on cigarettes may encourage people to use other combusted tobacco products, undermining the policy's effectiveness. The FDA is considering expanding the policy to include cigar products, which will require effective messages for people who use those products. AIMS AND

methodsIn 2022, a discrete choice experiment was conducted with African American males and females and White males and females. Participants (n = 1722), aged 18-44 years and who had smoked little cigars and cigarillos (LCCs) in the past 30 days, evaluated seven message attributes about reduced nicotine content (RNC) LCCs (presence or absence of information on source, chemicals, harm, nicotine, addiction, quitting efficacy, and enjoyment) across 20 choice sets. Participants assessed two of three outcomes: affect toward the policy, perceived harm of RNC LCCs, and motivation to quit smoking LCCs.

resultsMessages listing the FDA as the source were selected as eliciting more positive affect toward the policy, increasing perceived harm and motivation to quit smoking LCCs. Source was the most influential attribute for selecting messages in terms of positive affect toward the policy and motivation to quit. Chemicals and harm attributes had the most substantial effect on selecting messages as increasing perceived harm.

conclusionsCiting the FDA as a source may improve the perceived effectiveness of RNC communications for people who use LCCs. Misperceptions about presumed lower harms of RNC products can be corrected with information about their harm and chemical properties. IMPLICATIONS: Our findings among people who use LCCs suggest that source information shown as the FDA logo can increase message effectiveness while also influencing risk perceptions and motivation to quit smoking LCCs. To address misperceptions about RNC LCC harms, educational messages should particularly consider incorporating information about chemicals and harms.

Indexed as

Choice BehaviorCigar SmokingNicotineSmoking CessationTobacco ProductsAdolescentAdultBlack or African AmericanFemaleHumansMaleMotivationUnited StatesUnited States Food and Drug AdministrationWhiteYoung AdultNicotine

Identifiers

PMID39823307
PMCPMC12280172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.